Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Back

EHRA Premium Access

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Session: Ventricular tachycardia 4

Topic: Radiotherapy

Speaker: Associate Professor M. Tajstra (Zabrze, PL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

1 presentation

0 follower

8 more presentations in this session

Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR

Speaker: Associate Professor B. Dinov (Giessen, DE)

Cardiac tumors with life threatening arrhythmia, an eight year single centre experience

Speaker: Doctor O. Kamel (Aswan, EG)

Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation

Speaker: Doctor M. De Smet (Brugge, BE)

THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)

Speaker: Doctor O. Tovia Brodie (Jerusalem, IL)

Initial experience with ablation of ventricular arrhythmias using a pulsed-field system

Speaker: Doctor P. Stojadinovic (Prague, CZ)

Access the full session

Ventricular tachycardia 4

Speakers: Associate Professor M. Tajstra, Associate Professor B. Dinov, Doctor O. Kamel, Doctor M. De Smet, Doctor O. Tovia Brodie...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources